Grantclosed🌐 United StatesRFA-FD-25-001

Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical Trials Required

Food and Drug Administration

Details?

Posted: Aug 23, 2024
Response deadline: Oct 21, 2025, 12:00 AM UTC
Type: Grant
Category: 93.103
Status: closed
Buyer: Food and Drug Administration
Department: HHS-FDA
Jurisdiction: United States
Reference #: RFA-FD-25-001

Doc Type: synopsis
Opp Status: archived

Similar past solicitations

Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01) Clinical Trials Not Required
United States · Feb 17, 2021
Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required)
United States · Jan 8, 2025
Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required)
United States · Jan 13, 2025
Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)
United States · Jun 5, 2025
NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required)
United States · Nov 6, 2024
Optimizing Treatment Strategies for Adult Attention-Deficit Hyperactivity Disorder (ADHD) (R01 Clinical Trial Required)
United States · Sep 17, 2025

Finding similar opportunities…

This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.